Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case

Seattle-based PhaseRx Inc. went public in May 2016 and filed for Chapter 11 bankruptcy protection in December 2017.

Source: bizjournals.com Health Care:Physician Practices headlines - February 5, 2018 Category: American Health Authors: Casey Coombs Source Type: news